Biodegradable Dressings Market

Biodegradable Dressings Market Outlook (2023-2033)

Worldwide revenue from the biodegradable dressings market stands at US$ 204.10 Mn in 2022, with the global market estimated to surge ahead at a CAGR of 3.7% to reach a valuation of US$ 305.21 Mn by the end of 2033.

As assessed by Persistence Market Research, Polyvinyl alcohol (PVA) foams are expected to hold a market value of US$ 76.5 Mn by 2023. Overall, biodegradable dressings market sales account for approximately 1.9% revenue share in the global advanced wound care market, which was valued at around US$ 10.9 Bn in 2022.

Sales Analysis of the Global Market from 2016 to 2022 Vs Market Outlook for 2023 to 2033

The global market for biodegradable dressings recorded a historic CAGR of 3.1% in the last 8 years from 2016 to 2022.

Biodegradable dressings are promising options that have been found to improve mucosal healing, haemostasis, and comfort while also decreasing the risk of microbial infection. An increase in surgeries, a rise in medical conditions, and an ageing population will all lead to an increase in the demand for biodegradable dressings.

Moreover, the market is driven by the nasal dressing as many doctors are considering biodegradable dressing more and more due to its several beneficial properties. Fragmentable biodegradable nasal dressings are used after sinus and nasal procedures. These bandages biodegrade when the nasal cavity is regularly cleansed, eliminating the necessity for removal and lowering the possibility of harming the post-operative tissues.

Additionally, they improve local haemostasis, lower the likelihood of adhesions, and stop middle turbinate lateralization in addition to acting as a scaffold for better and quicker wound healing. Nasal blockage, pain during removal, haemorrhage, and postoperative pain are all considerably reduced with biodegradable nasal dressings.

Also, they are more easily accepted by the patient because of their porous nature, which reduces their breathing pain. These biodegradable nasal dressings are better suited for most uses because they have very few drawbacks.

Leading market players have started to use new product launches and approvals as a primary growth strategy. The second-most important strategy used by market participants is acquisitions. Companies have been able to increase both their geographical presence and their product offers by implementing these tactics.

The global market is thus likely to show high growth over the coming years at a CAGR of 3.7% and reach a global market size of US$ 305.21 Mn by 2033.

What Factors Will Drive the Market to Grow Over Forecast Duration?

“Growing Demand for Post-Operative Care Due to Increased Number of Surgeries”

Biodegradable dressings have been shown to decrease the risk of microbial infection while enhancing mucosal healing, haemostasis, and comfort. An increase in surgeries, is one of the primary factor responsible for the market’ growth. During surgeries, the biodegradable dressings considerably reduces nasal blockage, pain during removal, haemorrhage, and postoperative pain. They are more easily accepted by the patient because of their porous nature, which lessens their breathing pain.

• According to the article Elsevier Public Health Emergency Collection published in 2020, around 310 million major surgeries are performed every year.

Additionally, a rise in chronic illnesses such as diabetes mellitus, cardiovascular and chronic respiratory diseases, cancer, and stroke are supposed to increase the demand of biodegradable dressings during the forecast timeline. Diabetes Mellitus is a condition in which a small cut can lead to high bleeding, as there is a concurrent rise in plasma kallikrein levels. This can lead to continuous bleeding which is stopped using biodegradable dressings, thereby increasing the demand of it.

Furthermore, almost every country in the globe is seeing an increase in the number and percentage of senior citizens with increasing chronic conditions in its population which is also the reason supporting the biodegradable dressings market’ growth. For instance, according to World Population Ageing 2019, there were 703 million people worldwide who were 65 or older. In 2050, it is expected that there will be 1.5 billion senior people.

Moreover, leading market players have started to use new product launches and approvals as a primary growth strategy. The second-most important strategy used by market participants is acquisitions. Companies have been able to increase both their geographical presence and their product offers by implementing these tactics.

For instance, Baxter Healthcare Corporation subsidiary acquired some of the PerClot Polysaccharide Hemostatic System’s assets for upto US$ 60.8 Mn on July 7, 2021.

Is there Any Impact on the Growth of the Biodegradable Dressings Market?

“Increased Competition and Fragmented nature of Market”

Equipment used in the post-operative management of nasal surgeries, such as nasal dressings, might traumatise the surgical site and provide additional issues for the patient healing. This aspect may partially impede market expansion.

The fragmented character of the current market is another significant barrier. Due to the existence of regional industrial companies, no single organisation is now dominating this industry.

Along with well-known companies like Stryker, Medtronic, Baxter, and Smith & Nephew, other local businesses that manufacture nasal dressings also hope to increase their global sales. It is difficult for other businesses to enter the market because these regional competitors command a significant market share in their particular regions.

Country-wise Insights

Why is the U.S. Market Booming?

“Presence of Prominent Players”

The U.S. accounted for around 91.2% market share in the North America biodegradable dressings market in 2022. The growing demand in the U.S. for biodegradable dressings is due to increased prevalence of chronic conditions and an increase in surgical procedures.

Furthermore, presence of prominent market players such as Stryker and Baxter International with their acquisitions and expansions in this region is also the factor driving the regional growth.

• For instance, in December 2017, Stryker Corporation acquired Entellus Medical Inc. The innovative ENT devices from Stryker and Entellus will provide patients with the resources they require for healthcare solutions that are affordable.

Will Germany Be a Lucrative Market for Biodegradable Dressing Manufacturers?

“Rise in Geriatric Population”

Germany held around 25.2% market share of the Europe biodegradable dressings market in 2022. The country's rapidly ageing population with increasing disease conditions, implementation of policies for reimbursements especially in healthcare sectors and increasing provision of post- operative training in healthcare facilities are driving the regional market.

Other significant factors are the rise in chronic and respiratory illnesses as well as the number of emergency nasal visits, which are anticipated to present new business prospects for German manufacturers of biodegradable dressings.

How is Japan Emerging as a Prominent Market for Biodegradable Dressings?

“Increasing Patient with Chronic Disorder”

Japan held a market share of about 32.9% of the East Asia biodegradable dressings market in 2022. Rising cases of sinus disorders, hypertension among other chronic disorders among the patient, followed by growing FDA approvals for biodegradable dressing products and increasing R&D investments by public and private organization are the primary factors responsible for the regional growth.

For instance, according to Epidemiology of Chronic Critical Illness in Japan, A Nationwide Inpatient Database Study states that there were 2,395,016 ICU admissions, and 216,434 (9.0%) of those cases categorized as chronic critical illnesses.

Prolonged acute mechanical ventilation (73.9%) was the most prevalent qualifying condition, followed by sepsis with 50.6%, tracheostomy with 23.8%, and stroke with 22.8%. Mortality rates in hospitals overall were 28.6%.

Additionally, generalizing to national statistics in Japan, there were 46,494 instances of chronic critical illness in 2017 compared to 47,729 cases in 2011.

How is Australia Emerging as a Prominent Market for Biodegradable Dressings within Oceania?

“New Developments for Patient Care”

Australia held a market share of about 80.8% of the Oceania biodegradable dressings market in 2022 due to increasing product advancements. For instance, the Australian government agency CSIRO recently unveiled NovoSorb, a new nontoxic polymer with multiple degradation rates that can be utilised in skin grafts, particularly for the treatment of burns and wounds, to help heal broken bones and damaged cartilage.

Moreover, for burning dressing Alginate dressings, which are made from seaweed and are very absorbent and biodegradable, are used to absorb wound exudate. Strong hydrophilic gel formation is used to achieve the high absorption, and they maintain a moist wound environment that encourages healing and the growth of granulation tissue. They are helpful for wounds that are moderately to highly leaking. Algisite M, Kaltostat, and Melgisorb are some of the alginate dressing products available. All these factors are driving the growth in this region.

Category-wise Insights

Which Product is Driving Growth of the Global Market?

“Various Beneficial Advantages”

The polyvinyl alcohol (PVA) foam segment is dominating the product segment and are expected to hold a market value of US$ 76.5 Mn by 2023. The development of ideal wound dressings with better properties, such as fluid absorption capacity, drug release control ability, and improved wound healing, is currently a significant requirement for wound healing.

Applications for the compostable semi-crystalline synthetic polymer polyvinyl alcohol (PVA) in biotechnology include drug distribution systems, tissue regeneration, and wound healing. The advantages of PVA-based wound dressing materials, such as their biodegradability, bio - compatibility, non-toxicity, and cost, have recently attracted a lot of attention.

PVA can also be applied as a wound dressing to create the necessary moist environment, improve the dressing's physical properties, and accelerate wound healing. PVA can also be used to administer drugs and speed up the healing of wounds when coupled with other organic and inorganic materials. These affirmatory advantages of PVA are the reason driving for the segment’s growth.

Which End User Offers the Global Market a Profitable Outlook?

“Rising Number of Road Traffic Injuries”

Hospitals hold a market share of around 54.4% in 2022 and is supposed to grow fastest throughout the forecast duration. The easy availability of varied procedures and facilities makes the hospitals segment highly demanding. Furthermore, the demand for bio-materials such as biodegradable dressings, as widely used in post endoscopic sinus surgery for wound healing is very high in hospitals.

Competition Landscape

Biodegradable dressing manufacturers are actively looking to improve their position through partnerships, mergers and acquisitions, alliances, and agreements with both existing and up-and-coming industry players.

Product launches, technological developments, and acquisitions accelerate manufacturers' aim to grow their market share.

Key instances include:

• In August 2021, The WEREWOLF FASTSEAL 6.0 Haemostasis Wand for orthopaedist in recon business, was introduced by Smith & Nephew. The product help shorten process times and minimise blood loss by radio frequency technology.
• In May 2021, U.S. patent was granted to velNez, Datt Mediproduct’s recent biodegradable and biocompatible nasal dressing.
• In September 2017, Procedures Stealth Station ENT was introduced in ENT market by Medtronic. The system utilizes specialised electromagnetic technology to track the position of the tool during an ENT operation and target anatomy.

Biodegradable Dressings Industry Report Scope

Key Segments Covered in Biodegradable Dressings Industry Research

Product:

• Polyvinyl Alcohol (PVA) Foam
• Hyaluronic Acid
• Carboxymethyl Cellulose
• Fibrin Glue
• Microporous Polysaccharide Hemisphere
• Chitosan

End User

• Hospitals
• Clinics
• Ambulatory Surgical Centres

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

To know more about delivery timeline for this report Contact Sales